Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2025-12-26 @ 3:31 AM
NCT ID: NCT01789320
Description: None
Frequency Threshold: 0
Time Frame: 26 weeks
Study: NCT01789320
Study Brief: Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Triamcinolone Acetonide (Triesence®) TRIESENCE® (triamcinolone acetonide injectable suspension 40 mg/mL) in a total volume of 100 uL administered via microneedle directly to the suprachoroidal space (SCS) triamcinolone acetonide (Triesence®): 4 mg of TRIESENCE® (triamcinolone acetonide injectable suspension 40 mg/mL) administered as a single injection to the suprachoroidal space 0 None 1 11 11 11 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Pulmonary embolism NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA v.17.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Cataract NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Cystoid macular oedema NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Cystoid macular oedema NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Eye irritation NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Eye pain NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Eyelid margin crusting NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Punctate keratitis NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Retinal ischaemia NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Retinal neovascularisation NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Uveitis NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Vision blurred NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Visual acuity reduced NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Visual acuity reduced NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Pyrexia NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Localised infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.1) View
Sinusitis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.1) View
Urinary tract infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.1) View
Ligament injury NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (17.1) View
Ligament sprain NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (17.1) View
Tendon injury NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (17.1) View
Neck pain NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Psychological trauma NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (17.1) View
Chronic obstructive pulmonary disease NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (17.1) View
Alopecia NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (17.1) View
Cataract operation NON_SYSTEMATIC_ASSESSMENT Surgical and medical procedures MedDRA (17.1) View